
Deepflare is an AI company focused on accelerating therapeutic pipelines in the biotech industry. They apply artificial intelligence to complex biological problems such as protein folding, binding, immunogenicity, and yield, aiming to make biology more predictable, programmable, and cost-efficient. Their platform offers solutions for vaccine design with integrated immunogenicity profiling, protein engineering for functional optimization, and AI-guided manufacturing analytics for cell therapies. Deepflare's technology helps reduce the need for extensive in vivo experiments and brute-force screening, enabling faster development of high-performing therapeutic candidates. The company's mission is to leverage cutting-edge technology and biopharma to enter a new age of therapeutic discovery, ultimately aiming for a future where diseases are no longer feared.

Deepflare is an AI company focused on accelerating therapeutic pipelines in the biotech industry. They apply artificial intelligence to complex biological problems such as protein folding, binding, immunogenicity, and yield, aiming to make biology more predictable, programmable, and cost-efficient. Their platform offers solutions for vaccine design with integrated immunogenicity profiling, protein engineering for functional optimization, and AI-guided manufacturing analytics for cell therapies. Deepflare's technology helps reduce the need for extensive in vivo experiments and brute-force screening, enabling faster development of high-performing therapeutic candidates. The company's mission is to leverage cutting-edge technology and biopharma to enter a new age of therapeutic discovery, ultimately aiming for a future where diseases are no longer feared.